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Objective: The associations of smoking and body mass index (BMI) with health-related quality of 
life (QoL) are not well understood among breast cancer survivors. We examined the QoL of breast 
cancer patients by smoking status and BMI (1) to determine if there are differences in physical and 
mental component summary (PCS and MCS) scores, (2) to evaluate whether there is an interaction 
between smoking and BMI on QoL, (3) to assess smoking pattern changes pre- and post-cancer 
diagnosis, and (4) to measure changes of physical and mental health by smoking status. 
Methods: In this study, we included 6,756 breast cancer patients from the SEER-MHOS linkage 
database (1998-2011) who were 65 to 95 years old (inclusive) and did not present with any other 
types of cancer. A multivariate linear regression model was used to measure differences in PCS 
and MCS scores in different smoking statuses and BMI categories. A subgroup analysis was 
performed among 604 patients who responded to surveys pre- and post-diagnosis. We evaluated 
the patients’ smoking behavior changes and assessed their mean PCS and MCS score changes by 
their smoking status. 
Results: After adjusting for patient demographics, cancer characteristics, and comorbidities, 
smoking was significantly associated with reduced PCS and MCS scores in breast cancer patients. 
Being underweight, overweight or obese was negatively correlated with physical health, while 
being underweight was significantly associated with a lower mental health score. There was no 
significant interaction between smoking and BMI on QoL. In our subgroup population, only about 
26.2% of the smokers quit after breast cancer diagnosis. In the unadjusted analysis, patients who 
quit smoking after cancer diagnosis showed greater physical health deterioration but less mental 
health decline compared to patients who continued smoking after diagnosis, or who never smoked. 




Conclusions: Smoking and non-normal BMI were associated with poorer QoL, indicating the need 
to support breast cancer patients who wish to quit smoking and pursue a healthy BMI. The results 
also suggest that achieving a normal BMI may have greater impact on the mental health of 
underweight individuals than on those who are overweight or obese. Almost 73.8% of cancer 
patients did not quit smoking after their cancer diagnosis, indicating a need for encouraging 
smoking cessation among breast cancer survivors. 
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Breast cancer is the most commonly diagnosed cancer among women, and it is also the 
leading cause of cancer mortality in women worldwide (Parkin & Fernandez, 2006). Globally, 
there are an estimated 4.4 million women living with breast cancer who are within 5 years of their 
diagnosis (Parkin, Bray, Ferlay, & Pisani, 2005). Breast cancer incidence increases with age in 
women. The risk is low before the age of 30 (25 in 100,000), then it shows a linear increase and 
peaks and plateaus at 80 (around 500 in 100,000) (Kartal, Tezcan, & Canda, 2013). Twenty one 
percent of the 207,000 new invasive breast cancers (43,000) were predicted to be in women aged 
75 or older in 2010 (Muss & Busby-Whitehead, 2011). Medical advances and technology progress 
have reduced overall mortality and increased human life-span (Cutler & McClellan, 2001). The 
rising life expectancy is increasing the number and proportion of elderly people, meaning the 65-
and-over population is growing consistently (Cutler & McClellan, 2001).  In 2012, the estimated 
number of the population aged 65 and over was 43.1 million, and this number will almost double 
by 2050, to 83.7 million (Ortman & Velkoff, 2014). Given the aging of the US population, it is 
important to improve the current health and future health outcomes of the elderly. A breast cancer 
survivor at the age of 65 or 75 years can be expected to live an additional 20 or 13 more years, 
respectively, if they do not die from breast cancer (Muss & Busby-Whitehead, 2011).   
Smoking is associated with reduced effectiveness of cancer treatment and an increased risk 
of secondary cancer (Giovino, 2007). Furthermore, prior research indicates that smoking has a 
negative impact on the QoL of cancer survivors (National Cancer Institute, 2014), although the 
exact mechanisms are unclear. Smoking is associated with many other chronic diseases and 
depression (Stafford, Berk, & Jackson, 2013). Almost 50% of the women with early stage breast 
cancer had depression or anxiety (Burgess et al., 2005). In addition, smoking contributes to poor 




physical function in elderly women (Nelson, Nevitt, Scott, Stone, & Cummings, 1994). Breast 
cancer patients who are current longtime smokers have worse prognosis than non-smokers, but 
those who quit after diagnosis do not (Ahmad Kiadaliri, Bastani, & Ibrahimipour, 2012). While 
smoking negatively impacts the QoL of patients with smoking-related cancers, whether smoking 
is associated with decreased QoL of breast cancer patients is under debate. In a recent study, 
although smoking negatively affected cognitive functioning of breast cancer patients and 
decreased their survival, there was a lack of evidence that smoking was associated with poor 
emotional or physical health in these patients (Ahmad Kiadaliri et al., 2012). Smoking also leads 
to various chronic conditions in older adults, and these conditions always cause pain and loss of 
function, decrease QoL, and increase costs for health care and long-term care (Centers for Disease 
Control and Prevention, 2009). It has been reported that people with smoking-related cancers are 
more likely to stop smoking or make serious efforts to quit at the time of diagnosis (Gritz, 
Nisenbaum, Elashoff, & Holmes, 1991; Ostroff et al., 1995). However, the overall smoking rates 
were similar between female cancer survivors and women who do not have cancer (Mayer & 
Carlson, 2011). Taken together, the current literature regarding the impact of smoking on the QoL 
of breast cancer survivors is limited. 
BMI has long been linked to QoL (Finkelstein, 2000). A higher BMI was associated with 
poor QoL among survivors of uterine cancer and endometrial cancer (Fader, Frasure, Gil, Berger, 
& von Gruenigen, 2011; Lin, Brown, Segal, & Schmitz, 2014), as well as decreased overall 
survival in prostate cancer patients receiving radiotherapy (Smyth, 2015). BMI impacts physical 
function, which, in turn, influences mood. Previous research shows that obese or overweight 
women are more likely to have anxiety, depression and lower well-being (Jorm et al., 2003). Little 
is known about whether such associations exist within breast cancer survivors.  




Prior literature has demonstrated a strong relationship between smoking and BMI (Sneve 
& Jorde, 2008). However, research examining how smoking and BMI influence the QoL of elderly 
breast cancer survivors is limited. Understanding whether there is a synergetic effect of smoking 
and BMI on QoL has the potential to provide valuable information to policymakers, healthcare 
providers, and patients and their families, possibly leading to effective interventions that allow 
patients to live longer with a higher QoL. 
The objective of this study is to assess self-reported QoL among 65 to 95 year-old 
Medicare-enrolled breast cancer patients by smoking status and BMI, and to evaluate whether 
there is an interaction between smoking and BMI on QoL. We also aim to assess smoking patterns 
and behavior changes of breast cancer patients before and after diagnosis and measure the changes 




We used linked data from the Center of Medicare and Medicaid Services (CMS) Medicare 
Health Outcomes Survey (MHOS) and the National Cancer Institute’s Surveillance, Epidemiology 
and End Results (SEER) program. The SEER program includes nearly 28% of the US population 
and provides authoritative data on cancer incidence and survival in the US. Out of the 18 
population-based cancer registries affiliated with SEER, 14 participated in the SEER-MHOS 
linkage. The MHOS was designed as an ongoing, 2-year longitudinal cohort survey of Medicare 
beneficiaries enrolled in managed-care plans nationwide, starting in 1998 (Ambs et al., 2008), and 
it included more than 400 Medicare Advantage managed-care plans (National Cancer Institute, 




2015). The survey was administered to a random sample of 1,000 Medicare beneficiaries from 
each managed care plan under contract with CMS. It was designed to measure the health status 
and outcomes within each participating Medicare + Choice (M+C) managed care plan in order to 
provide risk-adjusted measures of plan performance as well as to assess population-based 
outcomes of care (Stevic et al., 2000). The current linked SEER-MHOS database includes twelve 
cohorts of MHOS data (baseline and follow up) collected between 1998 and 2011.  
 
Study Sample 
 A total of 20,021 female breast cancer patients were initially identified by the SEER 
program from 1998 – 2011. Of these patients, we first selected 10,165 between the ages of 65 and 
95 years (inclusive) who did not present with any other types of cancer. We then excluded 3,409 
patients for missing one or more of the following covariates: smoking status, age, race, education, 
marital status, region, high blood pressure, heart disease, stroke, chronic obstructive pulmonary 
disease (COPD), gastrointestinal (GI) disease, arthritis, diabetes, vision problems, hearing 
problems, or time since diagnosis.  As a result, the final sample size for this study was 6,756 
(Figure 1). 
 
Variables of Interest 
Dependent variables  
QoL was assessed by PCS and MCS scores using validated measures of SF-12, which is a 
12-item questionnaire measuring physical and mental health. As one of the most widely used 
instruments for assessing QoL (Nachar et al., 2013), SF-12 evaluates eight dimensions of health 




(physical functioning, role physical, bodily pain, general health, vitality, social functioning, role 
emotional, and mental health). PCS and MCS summary scores are standardized and normalized to 
the US general population and scaled from 0 to 100. The mean score is 50 and the standard 
deviation is 10. A higher PCS or MCS score represents better QoL in physical health or mental 
health, respectively (Boele et al., 2015). This standard-based scoring makes it possible to interpret 
scores by comparing them to those of a reference population. 
 
Independent variables 
The primary independent variables of this study were smoking status (smokers or non-
smokers) and BMI. BMI was categorized into 5 categories: underweight (BMI<18.5), normal 
(18.5≤BMI<25), overweight (25≤BMI<30), obese (BMI≥30), and unknown. We additionally 
examined cancer specific variables including time since cancer diagnosis (<2 years, 3-5 years, 6-
10 years, ≥11 years), breast cancer stage (Stage 0, Stage 1, Stage 2, Stage 3, Stage 4, unknown), 
and surgical treatment (breast-conserving surgery (BCS) only, BCS and radiotherapy, mastectomy 
with or without radiotherapy, unknown). The non-cancer specific variables we examined were: 
age (65 to <70, 70 to <75, 75 to <80, 80 to <85, 85 to <90, 90 to ≤95), race (white, black, other 
race), region (Northeast, Midwest, South, West), education level (less than high school, high 
school, college or higher education), household income (<$30,000, $30,000 to <$50,000, $50,000 
to <$100,000, ≥100,000, unknown), marital status (married, widowed, divorced/separated, never 
married), and medical comorbidity (including high blood pressure, heart disease, stroke, COPD, 
GI disease, arthritis, diabetes, vision problems, and hearing problems). 
 





The baseline characteristics of the subjects were summarized using mean (SD) for 
continuous variables, and N (proportion) for categorical variables. We used chi-square tests to 
compare baseline categorical characteristics and t-tests to compare baseline continuous variables 
between breast cancer patients who were smokers and those who were non-smokers. To study the 
association between smoking status and QoL (PCS and MCS), multivariate linear regression 
models adjusted for the baseline variables mentioned above were used. We also examined whether 
adding interaction terms between smoking and BMI affected PCS and MCS scores, and the results 
were presented as the least squares mean ± SD of PCS and MCS scores with p values. Statistical 
significance was considered at p <0.05. 
In order to understand whether smoking patterns had changed due to breast cancer 
diagnosis, we created a subgroup including patients who had responded to surveys both before and 
after cancer diagnosis and obtained data on their smoking behaviors from both surveys. The 
surveys they took closest to their diagnosis dates were the ones used for analysis. Patients included 
in this subgroup analysis were divided into 4 categories: (1) smoker both before and after diagnosis 
(smokers); (2) smoker before diagnosis but non-smoker after diagnosis (quitters); (3) non-smoker 
before diagnosis but smoker after diagnosis (starters); (4) non-smoker both before and after 
diagnosis (non-smokers).  Furthermore, we assessed the PCS and MCS scores of these 4 groups 
of patients based on their pre- and post-diagnosis surveys. Because only very few non-smokers 
would be expected to start smoking after diagnosis, we combined starters and non-smokers into 
one group as non-smokers. Smokers, quitters, and non-smokers are the ones in which we are most 
interested. Therefore, the changes in PCS and MCS scores before and after cancer diagnosis of 
these 3 groups were plotted in 2 graphs.  









 Among the 6,756 breast cancer patients who had been diagnosed from 1998 to 2011 and 
had responded to surveys after cancer diagnosis, 619 were smokers and 6,137 were non-smokers 
(Table 1). Smokers were more likely to be underweight and less likely to be overweight or obese 
compared to nonsmokers (2.6%, 14.1%, and 6.5% of smokers vs. 1.5%, 17.4%, and 14.3% of non-
smokers). Smokers had worse PCS and MCS scores compared to non-smokers (37.1 and 50.1 vs. 
38.2 and 51.6, respectively). The mean age of smokers was younger than that of non-smokers (73.8 
vs. 76.3, p<0.001). Smokers had a lower proportion of 85-to-<95 year-olds than non-smokers (4.4% 
vs. 11.6%). Education level was lower in smokers compared to non-smokers (35.1% vs. 42.2% 
received a college education or higher). Compared to non-smokers, smokers were more likely to 
have lower household income, be unmarried, and have a shorter time since diagnosis. There was 
no significant difference in race, region, cancer stage or surgical treatment between smokers and 
non-smokers. A lower percentage of smokers had high blood pressure, arthritis, and diabetes 
compared to non-smokers. However, the proportion of individuals who had COPD in the smoker 
group was approximately twice that of the non-smoker group (24.23% vs 12.99%). The 
distributions of heart disease, stroke, GI disease, vision, and hearing problems were very similar 
in the two groups. 
 




Factors Associated with PCS and MCS 
 In multivariate analyses, smoking status and BMI were significantly associated with PCS 
and MCS scores in patients who had responded to surveys after breast cancer diagnosis, controlling 
for other covariates mentioned above (Table 2). The PCS score and MCS score were 2.02 units 
and 1.10 units lower, on average, in smokers compared with non-smokers (p<0.001 and p=0.013, 
respectively). In contrast to normal weight patients, individuals who were underweight, 
overweight, obese, or who had an unknown BMI had worse physical health. The underweight, 
overweight, and obese groups had 3.08, 1.55, and 4.83 lower PCS average scores respectively than 
the normal weight group. Underweight patients had MCS scores that were 3.43 units lower on 
average compared to normal weight individuals. Overweight and obese individuals had similar 
MCS scores to normal weight patients. People living in the South and the West showed 
significantly lower PCS scores than those residing in the Northeast. A higher level of education or 
household income was associated with better physical and mental health in the study population. 
Never married patients demonstrated greater PCS and MCS scores compared to married people. 
Physical function was better among those who were diagnosed 11 years or more prior to the survey 
compared to those who were diagnosed less than 2 years ago. However, race and surgical treatment 
did not appear to be associated with QoL in breast cancer patients.  
 We also examined whether there were interactions between smoking status and BMI on 
the physical health and mental health of breast cancer patients. The results were not statistically 
significant (p>0.05).  
 





 In the subgroup of 604 breast cancer patients who responded to pre- and post-diagnosis 
surveys, 61 were smokers and 543 were non-smokers before cancer diagnosis. After cancer 
diagnosis, 16 out of 61 had quit smoking, and 6 out of 543 had started smoking. Other people 
maintained their smoking behavior after diagnosis (Table 3).  
 Among 602 patients who reported their PCS scores before and after cancer diagnosis, the 
unadjusted average PCS scores for the smokers, quitters, and non-smokers were 42.51, 41.98, and 
40.04 prior to diagnosis, and 39.74, 33.88, and 37.10 after diagnosis, respectively (Figure 2). The 
unadjusted average MCS scores for smokers, quitters, and non-smokers were 52.50, 52.88, and 
52.85 prior to diagnosis, and 49.26, 52.04, and 50.90 after diagnosis, respectively (Figure 3).  
 
Discussion 
 The results of this study indicate that smoking was significantly associated with poor self-
reported physical and mental health in breast cancer survivors, after controlling for patient 
demographics, breast cancer-related characteristics, and comorbidities. The study provides 
evidence that smoking negatively impacts the health of breast cancer survivors, although smoking 
is not considered an important risk factor for breast cancer incidence (Roddam et al., 2007).  
Our results showed that non-normal BMI was linked to decreased health outcomes of breast 
cancer patients. When evaluating BMI-related health outcomes in breast cancer patients, we 
controlled for smoking and other demographic, geographic and clinical characteristics. This, to 
our knowledge, has rarely been performed in previous studies (Wong, Lo, Wong, & Fung, 2013). 
Both physical and mental health were significantly worse in the underweight group than in the 




normal weight group. Overweight and obese individuals had significantly lower PCS scores in 
contrast to normal weight people measured by SF-12, but their MCS scores were not significantly 
different. These findings might be explained by the effects of BMI on the physiological function 
of body systems, body structures and functional mobility. An abnormally high BMI would reduce 
postural control and stability during walking, increase weight exertion on the knee, decrease 
neurocognitive function, and cause chronic pain (Forhan & Gill, 2013). Overweight and obese 
additionally impacts patients’ physical health by slowing walking speed and limiting adaptability 
and mobility. An increased risk of depression from being overweight or obese indicated by 
previous studies was not observed in breast cancer patients (Luppino et al., 2010). The physical 
functional limitation of underweight individuals may be caused by a smaller amount of muscle 
mass leading to lower muscle strength (Ahmed & Haboubi, 2010; Kikafunda & Lukwago, 2005; 
Sergi et al., 2007) and reduced physical activity (Sergi et al., 2007). Mental health impairment in 
underweight female cancer patients can be caused by reduced consumption of certain types of 
nutrients that are helpful in preventing depressive symptoms (Crisp & McGuiness, 1976; Crisp, 
Queenan, Sittampaln, & Harris, 1980). It is also possible that dietary patterns such as periodic 
eating protect against depression, anxiety and stress (Crisp & McGuiness, 1976; Crisp et al., 1980).  
On the other hand, mental health disorders may bi-directionally cause or aggravate body weight 
loss through anorexia nervosa (Crisp & McGuiness, 1976; Crisp et al., 1980). Therefore, being 
underweight is closely related to negative emotional health outcomes. 
 There were 604 patients in total who had indicated their smoking status in surveys pre- and 
post-diagnosis, and 26.2% smokers quit smoking after they were diagnosed with breast cancer (16 
out of 61).  In order to assess how physical and mental health changed after cancer diagnosis in 
patients with different smoking statuses, their PCS and MCS scores before and after diagnosis 




were compared. The pre-cancer diagnosis PCS scores were 42.51, 41.98, and 40.04 for the smokers, 
quitters, and non-smokers respectively. At baseline, the smoking group had the best physical health, 
while the non-smokers had the worst. After cancer diagnosis, the quitters had a much greater 
decrease of PCS scores compared to the smokers and non-smokers (8.10 vs 2.77 and 2.94). The 
unadjusted analysis showed that quitting smoking negatively affected the physical health of breast 
cancer patients. However, those patients who quit smoking might have had worse health compared 
to others, which forced them to stop smoking. The MCS scores were very similar across these 
three groups of people before cancer diagnosis. After cancer diagnosis, quitters had the lowest 
decrease of MCS scores (0.84), while smokers had the highest decrease (3.24). Therefore, smoking 
cessation probably had beneficial effects on preventing or reducing depression, anxiety, and stress 
caused by breast cancer. The effect size could be larger in patients with psychiatric disorders 
(Taylor et al., 2014). Through subgroup analysis, we found that smoking cessation was protective 
for mental health after cancer diagnosis in breast cancer patients. Therefore, it might be helpful to 
encourage smoking cessation in breast cancer patients to promote mental health. Further research 
on smoking cessation and physical health should be conducted, as our finding regarding physical 
health appeared counterintuitive.  
Major strengths of the current study include a population-based study design, a clearly-
defined target population (only primarily diagnosed breast cancer patients), and comprehensive 
covariate adjustment. The population-based study design enhances the validity and 
generalizability of the findings (Sorlie & Wei, 2011). Our target study population was breast 
cancer patients without any other types of cancer. This prevented the possible effects of other 
cancers on patients’ health. In order to accurately measure the association between smoking status, 
BMI and QoL, detailed demographic information, geographic variables, and clinical factors were 




adjusted in the regression models. In addition, our study provided novel data regarding changes in 
smoking patterns among breast cancer patients after diagnosis, which had not been evaluated in 
previous studies. The analysis of the changes in PCS and MCS scores among the smokers, quitters, 
and non-smokers sheds lights on how physical and mental health might be related to smoking 
status.  
This study also has several limitations. The analysis of cross-sectional data makes it 
difficult to assess the temporal relationship of different variables. Some of the data were obtained 
from self-reported surveys and could be subject to information bias. Some patients had missing 
data on BMI, household income, and cancer stage, reducing the statistical power and possibly even 
affecting the validity of the results. In addition, we only categorized smoking status based on 
cigarette use at the time of the survey. Among the non-smokers, it is possible that those who never 
smoked in their lifetime may have different PCS and MCS scores than former smokers. 
Furthermore, although our overall sample size was rather large, the power for some of the analyses, 
such as the analysis of potential interactions between smoking status and BMI, might have been 
limited.  
In the subgroup analysis, only 16 patients quit smoking after breast cancer diagnosis. The 
small sample size might have led to difficulty in measuring the changes in PCS and MCS scores 
after diagnosis. In addition, changes in physical and mental health pre- and post-diagnosis were 
assessed without adjusting for other covariates. Therefore, the negative effects of smoking 
cessation on PCS scores could have been influenced by other factors. It is possible that quitters 
had more severe cancer progression (Stage 3 or Stage 4) compared to other groups of patients. 
Other factors such as socioeconomic status and comorbidity also could have contributed to the 
observed associations. For each patient, we only used two surveys that were taken around the date 




of diagnosis (before and after). Analyzing longitudinal data over an extended period of time and 
analyzing a larger sample would be helpful in understanding how smoking cessation affects breast 
cancer patients’ health in the long term.  
Future research should focus on identifying the optimal strategies for supporting those who 
would like to quit smoking and those who hope to maintain a healthy BMI in order to achieve 
positive health outcomes in the long term. Prospective studies designed to better understand the 
QoL of breast cancer patients are desired. Healthcare providers and policy-makers should pay 
attention to the effects of smoking and BMI on the QoL of breast cancer patients, and seek the best 
ways to communicate such information to patients. 
 
Conclusions 
In this study, smoking and BMI were significantly associated with the QoL of breast cancer 
patients. Cigarette smoking was related to lower PCS and MCS scores. Being underweight, 
overweight or obese was negatively correlated with physical health, while being underweight was 
significantly associated with poorer mental health. Only a small proportion of breast cancer 
patients (26.2%) stopped smoking after cancer diagnosis. Greater efforts need to be made to inform 
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Figure 2. PCS Change by Smoking Status 
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Table 1. Characteristics of 6,756 Breast Cancer Patients Diagnosed between 1998 and 2011, 
by Smoking Status 
 
 





    
PCS (SD)a 37.1 (11.9) 38.2 (12.1) 0.039 
MCS (SD)b 50.1 (10.8) 51.6 (10.9) 0.001 
BMI 
16 2.6 91 1.5 
<0.001 
Underweight  
Normal 98 15.8 1250 20.4  
Overweight 87 14.1 1067 17.4  
Obese 40 6.5 875 14.3  
Unknown 378 61.1 2854 46.5  
Demographics    
Mean Age (SD) 73.8 (5.6) 76.3 (6.7) <0.001 
Age 
186 30.1 1291 21.0 
<0.001 
65-<70  
70-<75 208 33.6 1600 26.1  
75-<80 143 23.1 1494 24.3  
80-<85 55 8.9 1041 17.0  
85-<95 27 4.4 711 11.6  
Race 
517 83.5 5008 81.6 
0.100 
White  
Black 42 6.8 362 5.9  
Other 60 9.7 767 12.5  
Region 
88 14.2 866 14.1 
0.271 
Northeast  
Midwest 62 10.0 604 9.8  
South 97 15.7 796 13.0  
West 372 60.1 3871 63.1  
Education 
138 22.3 1272 20.7 
0.002 
Less than high school  
High School 264 42.7 2276 37.1  










College or higher 217 35.1 2589 42.2  
Income 
370 59.8 2999 48.9 
<0.001 
<30K  
30K-<50K 92 14.9 1088 17.7  
50K-<100K 31 5.0 609 9.9  
≥100K 10 1.6 135 2.2  
Unknown 116 18.7 1306 21.3  
Marital Status 
212 34.3 2751 44.8 
<0.001 
Married  
Widowed 254 41.0 2462 40.1  
Divorced/Separated 139 22.5 733 11.9  
Never Married 14 2.3 191 3.1  
Clinical factors      
Surgical Treatment 
23 3.7 203 3.3 
0.081 
BCS only  
BCS and Radiotherapy 73 11.8 631 10.3  
Mastectomy with/without 
Radiotherapy 155 25.0 1333 21.7 
 
Unknown 368 59.5 3970 64.7  
Stage 
71 11.5 651 10.6 
0.450 
Stage 0  
Stage 1 170 27.5 1720 28.0  
Stage 2 108 17.5 907 14.8  
Stage 3 & 4 11 1.8 94 1.5  
Unknown 259 41.8 2765 45.1  
High Blood Pressure 
262 42.3 2195 35.8 
0.001 
No  
Yes 357 57.7 3942 64.2  
Heart Disease 
451 72.9 4272 69.6 
0.093 
No  
Yes 168 27.1 1865 30.4  











565 91.3 5673 92.4 
0.300 
No  
Yes 54 8.7 464 7.6  
COPD 
469 75.8 5340 87.0 
<0.001 
No  
Yes 150 24.2 797 13.0  
GI Disease 
585 94.5 5831 95.0 
0.583 
No  
Yes 34 5.5 306 5.0  
Arthritis 
250 40.4 2111 34.4 
0.003 
No  
Yes 369 59.6 4026 65.6  
Diabetes 
528 85.3 4863 79.2 
<0.001 
No  
Yes 91 14.7 1274 20.8  
Vision Problem 
578 93.4 5746 93.6 
0.807 
No  
Yes 41 6.6 391 6.4  
Hearing Problem 
565 91.3 5482 89.3 
0.132 
No  
Yes 54 8.7 655 10.7  
Time since Diagnosis 
128 20.7 1320 21.5 
0.049 
<2 years  
3-5 years 183 29.6 1560 25.4  
6-10 years 154 24.9 1463 23.8  
≥11 years 154 24.9 1794 29.2  
 
a For the PCS, N = 6,754. 
b For the MCS, N = 6,726. 
 
 




Table 2.  Multivariate linear regression models predicting the Physical (PCS) and Mental 
(MCS) Component Summary scores among persons with breast cancer 
 
Characteristic 
PCS (N=6,754) MCS (N=6,726) 
Score (SE) p Score (SE) p 
Smoking status     
     Non-smoker Reference --- Reference --- 
     Smoker -2.015 (0.443) <0.001 -1.098 (0.442) 0.013 
 BMI     
     Normal weight Reference --- Reference --- 
     Underweight -3.076 (1.036) 0.003 -3.425 (1.030) 0.001 
     Overweight -1.553 (0.416) <0.001 0.280 (0.414) 0.498 
     Obese -4.834 (0.456) <0.001 0.658 (0.454) 0.147 
     Unknown -2.582 (0.354) <0.001 -0.785 (0.353) 0.026 
Age (years)     
     65-<70 Reference --- Reference --- 
     70-<75 -1.225 (0.362) 0.001 -0.102 (0.361) 0.777 
     75-<80 -2.849 (0.380) <0.001 -0.201 (0.378) 0.595 
     80-<85 -5.652 (0.434) <0.001 -0.453 (0.432) 0.295 
     85-<90 -6.463 (0.546) <0.001 -0.922 (0.545) 0.091 
     90-<85 -8.533 (0.856) <0.001 -1.466 (0.855) 0.086 
Race/ethnicity     
     White Reference --- Reference --- 
     Black -0.077 (0.555) 0.890 -0.048 (0.554) 0.930 
     Other 0.221 (0.399) 0.579 0.020 (0.397) 0.960 
Region     
     Northeast Reference --- Reference --- 
     Midwest -0.870 (0.525) 0.098 1.256 (0.523) 0.016 
     South -1.414 (0.486) 0.004 -0.222 (0.484) 0.647 
     West -1.494 (0.385) <0.001 0.450 (0.385) 0.242 
Educational level (years)     
     Less than high school Reference --- Reference --- 
     High school 0.960 (0.348) 0.006 2.815 (0.347) <0.001 
     College or higher 2.146 (0.361) <0.001 3.770 (0.360) <0.001 
Income     
     <30K Reference --- Reference --- 
     30K-<50K 0.626 (0.367) 0.088 0.827 (0.365) 0.024 
     50K-<100K 2.018 (0.468) <0.001 1.866 (0.467) <0.001 
     ≥100K 2.218 (0.888) 0.013 2.339 (0.883) 0.008 
     Unknown 0.372 (0.328) 0.257 0.643 (0.327) 0.049 
Marital status     
     Married Reference --- Reference --- 
     Widowed 0.492 (0.301) 0.102 -0.089(0.300) 0.768 
     Divorced/Separated 0.151 (0.409) 0.713 -0.514 (0.407) 0.207 
     Never Married 1.708 (0.748) 0.023 1.447 (0.746) 0.052 
Surgical Treatment     
     BCS Reference --- Reference --- 
     BCS + radiotherapy 0.492 (0.791) 0.534 0.799 (0.789) 0.311 
     Mastectomy +/- 
radiotherapy -0.876 (0.744) 0.239 0.650 (0.743) 0.381 




     Unknown -0.507 (0.730) 0.487 0.570 (0.730) 0.435 
Stage     
     0 Reference --- Reference --- 
     1 -0.971 (0.452) 0.032 -1.094 (0.451) 0.015 
     2 -1.877 (0.503) <0.001 -1.148 (0.501) 0.022 
     3 -2.309 (1.213) 0.057 -2.063 (1.206) 0.087 
     4 -9.130 (2.087) <0.001 -1.614 (2.075) 0.437 
     Unknown -1.270 (0.436) 0.004 -1.068 (0.435) 0.014 
High blood pressure     
     Yes -2.283 (0.274) <0.001 -0.711 (0.273) <0.001 
     No Reference --- Reference --- 
Heart disease     
     Yes -3.646 (0.283) <0.001 -1.513 (0.282) <0.001 
     No Reference --- Reference --- 
Stroke     
     Yes -3.846 (0.483) <0.001 -2.905 (0.481) <0.001 
     No Reference --- Reference --- 
COPD     
     Yes -3.942 (0.366) <0.001 -1.980 (0.365) <0.001 
     No Reference --- Reference --- 
GI disease     
     Yes -2.292 (0.576) <0.001 -4.024 (0.576) <0.001 
     No Reference --- Reference --- 
Arthritis     
     Yes -5.894 (0.268) <0.001 -2.290 (0.266) <0.001 
     No Reference --- Reference --- 
Diabetes     
     Yes -2.659 (0.326) <0.001 -1.482 (0.325) <0.001 
     No Reference --- Reference --- 
Vision     
     Yes -3.627 (0.528) <0.001 -5.237 (0.530) <0.001 
     No Reference --- Reference --- 
Hearing     
     Yes -1.504 (0.419) <0.001 -2.693 (0.418) <0.001 
     No Reference --- Reference --- 
Time since diagnosis 
(years)     
     <2 Reference --- Reference --- 
     3-5 0.207 (0.371) 0.577 0.069 (0.370) 0.852 
     6-10 0.635 (0.398) 0.111 0.572 (0.396) 0.149 














Table 3. Distribution of Subjects by Smoking Status Pre- and Post-Cancer Diagnosis 




Smoker 45 16 61 
Non-smoker 6 537 543 
Total 51 553 604 
 
 
 
 
